Houston Methodist Dr. Mary and Ron Neal Cancer Center Cancer Research Program Brochure

Houston Methodist Dr. Mary and Ron Neal Cancer Center

Cancer Research Program

Overall Goals & Objectives The Houston Methodist Dr. Mary and Ron Neal Cancer Center has built distinguished research and clinical enterprise impacting the lives of patients within its Catchment Area. Under the leadership of Jenny C. Chang, MD, the Cancer Center is on the trajectory of scientific growth while actively pursuing National Cancer Institute (NCI) designation. The Cancer Center is nationally recognized for its distinct research capabilities focused on breast cancer, immunotherapies, and using nanotechnologies to improve cancer therapeutics. Houston Methodist physicians and scientists are committed to the discovery and translation of cutting-edge therapies so that the best treatments are available to patients.

Our experts are dedicated to ensuring research participation is available to every patient who has a medical need and desire to participate.

10.6M

73

53

PEER-REVIEWED CANCER FUNDING

PEER-REVIEWED PROJECTS

INTERVENTIONAL CLINICAL TRIALS

RELEVANT ARTICLES IN TOP-TIER JOURNALS

57

10.05

93,000

407

CANCER CENTER MEMBERS 2

45

AVERAGE IMPACT SCORE

SQ. FT. CANCER CENTER RESEARCH SPACE

RESEARCH TRAINEES

Cancer Research Programs Innovative Therapeutics The program goals are to develop effective treatment for local advanced and metastatic cancers, with a primary

“

As a rapidly

expanding Cancer Center, we are uniquely positioned

focus on overcoming therapy-resistance, and to enrich

to bring novel therapies to

therapeutic agents in the tumor tissue through targeted

patients diagnosed with

drug delivery.

Cancer Immunology and Immunotherapy The program combines the close integration of basic biomedical sciences, translational research and, clinical

cancer. As evidenced by the deep expertise of our clinical faculty and translational scientists, Houston Methodist

trials of immune therapies to advance and translate

serves as an ideal institution

immunotherapies for solid and hematologic tumors.

for the development of impactful ideas and experiences

Cancer Prevention and Control

that will provide a foundation

The program goals are to identify, understand, and

for the future.

mitigate factors that contribute to cancer risk and to develop and evaluate new strategies for early cancer detection, including novel biomarkers.

”

– J enny C. Chang, MD Emily Herrmann Presidential Distinguished Chair in Cancer Research & Director, Dr. Mary and Ron Neal Cancer Center Professor of Medicine in Oncology, Houston Methodist Academic Institute

CATON Houston Methodist Neal Cancer Center Cancer Research Program Email: basicscience@houstonmethodist.org houstonmethodist.org/cancer-research-program

Houston Methodist Hospital is ranked among the nation’s top 25 hospitals for cancer.

3

Houston is a vibrant city comprised of diverse communities that reflect global influences, who enjoy a great variety of cultural amenities, world-class restaurants and an affordable cost of living. Houston Methodist is based in the heart of the Texas Medical Center, the largest medical center in the U.S. — just a short walk from the city’s museum and arts district, zoo and midtown attractions, and a few miles from Houston’s downtown and sports arenas.

HOUSTON, TX

HMRI Office HMRI of Communications Office of Communications & External Relations & External | COE-CC-22-00813 Relations | XXXXXXXXXXX | EG | DH | EG | 032022 | DH | 03.2022